Carnegie Mellon University Vera Therapeutics, Inc. Transaction History
Carnegie Mellon University
- $96.8 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
185Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$141 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$129 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$109 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$97 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$91.6 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $886M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...